Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:19 pm Purchase | 2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Suvretta Capital Management, LLC | 2,375,571 5.900% | 578,653 (+32.20%) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Fulcrum Therapeutics, Inc. FULC | FMR LLC | 6,082,317 14.999% | 37,554 (+0.62%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | BlackRock Inc. BLK | 2,208,078 5.400% | 2,208,078 (New Position) | Filing History |
| 2021-09-27 06:01 am Unchanged | 2021-08-16 | 13G | Fulcrum Therapeutics, Inc. FULC | GSK plc | 1,785,714 4.500% | 0 (Unchanged) | Filing History |
| 2021-09-10 09:33 am Purchase | 2021-09-09 | 13G | Fulcrum Therapeutics, Inc. FULC | FMR LLC | 6,044,763 14.999% | 4,295,027 (+245.47%) | Filing History |
| 2021-08-10 5:05 pm Purchase | 2021-08-04 | 13G | Fulcrum Therapeutics, Inc. FULC | Suvretta Capital Management, LLC | 1,796,918 5.500% | 1,796,918 (New Position) | Filing History |
| 2021-02-16 3:22 pm Sale | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Point72 Asset Management, L.P. | 1,338,668 4.900% | -43,340 (-3.14%) | Filing History |
| 2021-02-16 11:16 am Sale | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Foresite Capital Fund IV, L.P. | 0 0.000% | -1,500,000 (Position Closed) | Filing History |
| 2021-02-12 10:12 am Unchanged | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 2,071,409 7.540% | 0 (Unchanged) | Filing History |
| 2021-02-11 10:23 am Purchase | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Casdin Capital LLC | 1,241,176 4.520% | 1,891 (+0.15%) | Filing History |
| 2021-02-08 10:23 am Purchase | 2021-02-05 | 13G | Fulcrum Therapeutics, Inc. FULC | FMR LLC | 1,749,736 6.371% | 48,985 (+2.88%) | Filing History |
| 2020-11-13 09:57 am Purchase | 2020-11-03 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 2,071,409 7.550% | 2,071,409 (New Position) | Filing History |